These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3510796

  • 1. Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response.
    Donnelly M, Zametkin AJ, Rapoport JL, Ismond DR, Weingartner H, Lane E, Oliver J, Linnoila M, Potter WZ.
    Clin Pharmacol Ther; 1986 Jan; 39(1):72-81. PubMed ID: 3510796
    [Abstract] [Full Text] [Related]

  • 2. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS.
    Clin Pharmacol Ther; 1990 Jul; 48(1):57-66. PubMed ID: 2196146
    [Abstract] [Full Text] [Related]

  • 3. Plasma MHPG in depression: effects of acute and chronic desipramine treatment.
    Charney DS, Heninger GR, Sternberg DE, Roth RH.
    Psychiatry Res; 1981 Oct; 5(2):217-29. PubMed ID: 6945615
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment.
    Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D.
    Arch Gen Psychiatry; 1985 Oct; 42(10):969-73. PubMed ID: 2412521
    [Abstract] [Full Text] [Related]

  • 5. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO, Javaid J, Davis JM, Bylund DB.
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [Abstract] [Full Text] [Related]

  • 6. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
    Zametkin AJ, Hamburger SD.
    Biol Psychiatry; 1988 Feb 15; 23(4):350-6. PubMed ID: 3342265
    [Abstract] [Full Text] [Related]

  • 7. The effect of desmethylimipramine on the metabolism of norepinephrine.
    Zavadil AP, Ross RJ, Calil HM, Linnoila M, Blombery P, Jimerson DC, Kopin IJ, Potter WZ.
    Life Sci; 1984 Sep 03; 35(10):1061-8. PubMed ID: 6482645
    [Abstract] [Full Text] [Related]

  • 8. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
    Donnelly M, Rapoport JL, Potter WZ, Oliver J, Keysor CS, Murphy DL.
    Arch Gen Psychiatry; 1989 Mar 03; 46(3):205-12. PubMed ID: 2645848
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment, and methodological hazards.
    Veith RC, Bielski RJ, Bloom V, Fawcett JA, Narasimhachari N, Friedel RO.
    J Clin Psychopharmacol; 1983 Feb 03; 3(1):18-27. PubMed ID: 6833519
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary catecholamines and amphetamine excretion in hyperactive and normal boys.
    Rapoport JL, Mikkelsen EJ, Ebert MH, Brown GL, Weise VK, Kopin IJ.
    J Nerv Ment Dis; 1978 Oct 03; 166(10):731-7. PubMed ID: 702130
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of desipramine in endogenomorphically depressed patients.
    Stewart JW, Quitkin F, Fyer A, Rifkin A, McGrath P, Liebowitz M, Rosnick L, Klein DF.
    J Affect Disord; 1980 Sep 03; 2(3):165-76. PubMed ID: 6210722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
    Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS.
    J Am Acad Child Adolesc Psychiatry; 1989 Sep 03; 28(5):777-84. PubMed ID: 2676967
    [Abstract] [Full Text] [Related]

  • 18. Acute noradrenergic effects of desipramine in depression.
    Rudorfer MV, Sherer MA, Lane EA, Golden RN, Linnoila M, Potter WZ.
    J Clin Psychopharmacol; 1991 Feb 03; 11(1):22-7. PubMed ID: 2040714
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.